8,735
Views
4
CrossRef citations to date
0
Altmetric
Drug Profile

Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis

, ORCID Icon, &
Pages 515-529 | Received 20 Dec 2021, Accepted 08 Jun 2022, Published online: 11 Jul 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chi Chiu Mok. (2023) Combination strategies for lupus nephritis: facts and controversies. Expert Review of Clinical Immunology 19:5, pages 527-536.
Read now

Articles from other publishers (3)

Chen Cheng, Rongrong Zhu, Mingjian Liu, Hao Yang, Fangfang Guo, Qunqun Du, Xiaolan Wang, Minmin Li, Gaopeng Song, Renan Qin & Shuwen Liu. (2023) Kunxian capsule alleviates renal damage by inhibiting the JAK1/STAT1 pathway in lupus nephritis. Journal of Ethnopharmacology 310, pages 116349.
Crossref
Ajinath Kale, Maciej Lech, Hans-Joachim Anders & Anil Bhanudas Gaikwad. (2023) Lupus Nephritis: New and Emerging Biologic and Targeted Therapies. BioDrugs.
Crossref
Seung Hyeon Cha, Ji Hyeon Im & Yun-Kyoung Song. (2022) Analysis of Important Medical Adverse Events and Signals Related with Cyclosporine and Tacrolimus Using the FDA Adverse Event Reporting System (FAERS) Database. Korean Journal of Clinical Pharmacy 32:4, pages 352-361.
Crossref